ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Neurology

Top Neurology Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDWARD BERTRAM

Neurology

541

$263K

39
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 26%

$487
Average prescription price

Avg: $241

BRYANT RAMIREZ MD

Neurology

530

$33.6K

110
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $241

JINNY TAVEE MD

Neurology

528

$465K

95
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$881
Average prescription price

Avg: $241

RENZO FIGARI JORDAN M.D.

Neurology

518

$68K

176
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 26%

$131
Average prescription price

Avg: $241

HILARY NEWGEN M.D.

Neurology

501

$63.6K

147
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 26%

$127
Average prescription price

Avg: $241

MARY RANSOM MD

Neurology

492

$34.8K

136
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 26%

$71
Average prescription price

Avg: $241

DONALD LAMARCHE MD

Neurology

491

$93.8K

101
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 26%

$191
Average prescription price

Avg: $241

WARREN FELTON M.D.

Neurology

490

$161K

56
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 26%

$329
Average prescription price

Avg: $241

SIDNEY MALLENBAUM MD

Neurology

489

$146K

50
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$299
Average prescription price

Avg: $241

SETH TUWINER M.D.

Neurology

483

$37.5K

64
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 26%

$78
Average prescription price

Avg: $241

MAHA ALATTAR MD

Neurology

467

$46.5K

63
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 26%

$100
Average prescription price

Avg: $241

THA U M.D.

Neurology

459

$118K

78
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 26%

$257
Average prescription price

Avg: $241

DAVID SCHIFF M.D.

Neurology

457

$49.8K

78
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 26%

$109
Average prescription price

Avg: $241

NICOLE DIETZ MD, PHD

Neurology

450

$164K

65
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 26%

$365
Average prescription price

Avg: $241

EDWARD ISAACS MD

Neurology

447

$27.8K

46
34 are 65+

26%
patients receiving schedule two controlled substances

Avg: 4%

54%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $241

CHRISTOPHER SCHERER M.D.

Neurology

421

$226K

80
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 26%

$536
Average prescription price

Avg: $241

ROBERT DELORENZO M.D.

Neurology

419

$191K

61
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 26%

$457
Average prescription price

Avg: $241

HEIDI CRAYTON MD

Neurology

417

$282K

35
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 26%

$677
Average prescription price

Avg: $241

AMELITO MALAPIRA M.D.

Neurology

406

$77.7K

68
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$191
Average prescription price

Avg: $241

RICHARD CHO M.D.

Neurology

399

$78.4K

79
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 26%

$196
Average prescription price

Avg: $241

MATTHEW CHURCHILL M.D.

Neurology

398

$79.7K

80
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$200
Average prescription price

Avg: $241

HAIDEH SABET M.D.

Neurology

394

$68.5K

59
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 26%

$174
Average prescription price

Avg: $241

MADALINE HARRISON

Neurology

386

$45.6K

81
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 26%

$118
Average prescription price

Avg: $241

WILLIAM HIGHLANDER M.D.

Neurology

382

$76.6K

54
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

7%
prescriptions for brand name drugs

Avg: 26%

$200
Average prescription price

Avg: $241

BENJAMIN ADEWALE MD

Neurology

375

$42.9K

65
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 26%

$114
Average prescription price

Avg: $241

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank